3rd International Biomedical Research Meeting

June 10th 2011

Résidence de Marigny

Pr André Syrota

The French Alliance for Life and Health Sciences: Aviesan

Created in April 2009

To optimise scientific foresight and put forward scientific programming to Funding Agencies

To facilitate the development of top-level clusters and research centers

To promote national projects and to set up national core facilities

2

• Research operating agencies :• Inserm • CNRS life sciences department• CEA (atomic energy commission)• Inra (national institute for agricultural research)• Inria (computer science and automatic control)• IRD (research for development)• Pasteur Institute

• Universities• Hospitals

Ten Thematic Institutes covering the entire field of Life and health Sciences

NeurosciencesCognitive Sciences

Neurology, Psychiatry

Genetics, Genomics

Bioinformatics

ImmunologyHematologyRespiratory

diseases

MicrobiologyInfectiousdiseases

PublicHealth

HealthTechnologies

3

Cancer

Cell Biology

Development

Molecular and

Structural Biology

Nutrition

Circulation

Metabolism

Keywords: Sharing a common strategy to ensure an improved coordination

« Epidemiologie France » : a new internet portal for health research

• A web catalog of major health databases from French sources that may be useful to improve research and public health expertise

• This catalog contains descriptions of 237 databases including 130 cohort studies, 76 industrial studies and 31 morbidity registries

• A standardized description form for each database describes the main features: aims, population, methods, acces modes, responsible of the database

• Search engine and browse tools allows the visitor to explore the on line catalog in three ways: browse, simple and advanced search

• English version under construction

http://epidemiologie-france.fr

35 billion €

21.9 devoted to Research and Higher education

Investments for the future : a major opportunity for boosting R&I

• CANTO (breast cancer) : Institut Gustave Roussy / Inserm• OFSEP (multiple sclerosis) : Université Claude Bernard Lyon 1 / Hospices

civils de Lyon / Inserm• RADICO (rare diseases) : Inserm• i-SHARE (relationship between behaviour or exposure and pathogenesis

among young adults) : Université de Bordeaux / Inserm / Université de Versailles Saint Quentin

• E4N (genetics and biological risk factors) : Institut Gustave Roussy / Inserm• HOPE-EPI (pediatric cancers) : Inserm• CKD-REIN (chronic renal insufficiency) : Université Paris Sud 11• CRYOSTEM (transplant rejection and leukemia) : Société Française de

Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)• COBLAnce (bladder cancer) : Inserm• Psy-COH (chronic psychiatric disorders) : Fondation FondaMental

10 cohorts

70 millions € for 10 years

• BIOBANQUES (public health, biomarkers), coordination Inserm• F- CRIN (clinical research), coordination Inserm• HIDDEN (biosafety level 4 laboratory), Inserm • France-BioImaging (cell imaging), coordination CNRS• FRISBI (structural biology), coordination CNRS• PHENOMIN (phenotyping), coordination CNRS• ProFI (proteomics), coordination CNRS• France Génomique (genomics), coordination CEA• EMBRC-France (marine biology), université Pierre et Marie Curie, CNRS

9 national research infrastructures for biology and health

220 millions € for 10 years

• Neurosciences (Paris)• Cardiometabolism and nutrition (Paris)• Genetic diseases (Paris) • Cardiology (Bordeaux)• Surgery (Strasbourg)• Infectious diseases (Marseille)

6 university hospitals

« Instituts hospitalo-universitaires »

350 millions € for 10 years

10

www.aviesan.fr